Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins / tetracycline / iv dye, iodine containing contrast media attending: chief complaint: carboplatin desensitization major surgical or invasive procedure: none history of present illness: 63f with stage iiic poorly differentiated primary peritoneal serous carcinoma, now with disease recurrence and participating in a clinical trial, admitted to the icu for cycle 5 of /taxol therapy with carboplatin desensitization. one third of the way through infusion of carboplatin during cycle 2 of chemotherapy on , she developed an intense feeling of heat and generalized body tingling, numbness and tingling of the lips, and chest tightness. carboplatin was discontinued and she received 100 mg hydrocortisone and 50 mg of benadryl iv. her vital signs remained stable, but she later had vomiting and headache. given her allergic reaction, she was admitted to the icu to receive cycles 3 and 4 of carboplatin per the desensitization protocol. she has tolerated the treatments without incident. today, she is directly admitted to the icu again for carboplatin desensitization for cycle 5 of chemotherapy. on arrival to the micu, patient's vs: t 91, bp 122/71, hr 82, rr 19, spo2 93% ra. she denies any complaints, feels fine without pain, fever, nausea, vomiting, abdominal pain. review of systems: (+) per hpi (-) denies fever, chills, night sweats, headache, congestion, shortness of breath, cough, chest pain, palpitations, abdominal pain. past medical history: - stage iiic poorly differentiated primary peritoneal serous carcinoma - thalassemia - hypertension (per patient never treated with home medication, only when in hospital or seeing doctors) - gastritis/reflux oncologic history - ct abd/pelvis on revealed a large mass centered in the sigmoid colon with pelvic lymphadenopathy, retroperitoneal lymphadenopathy, and peritoneal carcinomatosis. - a colonoscopy revealed a fungating, ulcerated mass within the sigmoid colon causing a partial obstruction. the biopsy of this mass revealed adenocarcinoma with papillary formation, suggestive of an ovarian primary. - underwent exploratory laparotomy, hysterectomy, bilateral salpingo-oophorectomy, rectosigmoid resection with colorectal re anastomosis and diverting loop ileostomy. this was a suboptimal tumor debulking. intra-operatively, the uterus and bilateral adnexal were unremarkable. extensive firm retroperitoneal lymphadenopathy was appreciated. there was no evidence of carcinomatosis. the tumor was noted to involve the sigmoid colon and rectum. pathology examination revealed serous carcinoma involving full thickness of the rectal wall. seven of eight lymph nodes were positive for malignancy. uterus, cervix, fallopian tubes, and ovaries were negative for malignancy. - : 5 cycles of chemotherapy with carboplatin q21 days and weekly taxol, 6th cycle of chemotherapy with carboplatin and taxotere in place of taxol due to neurotoxicity - : mri of the l-spine shows new retroperitoneal lymphadenopathy consistent with disease recurrence. - started chemotherapy according to the clinical trial #11-228 (phase ii, multi-center, double-blind, placebo controlled, randomized study of ombrabulin in patients with platinum-sensitive recurrent ovarian cancer treated with carboplatin/paclitaxel) social history: immigrated from in youth. formerly employed in retail sales. no children, husband lives in . sister and live in area. - tobacco: never - etoh: denies - illicits: denies family history: mother and father lived to their 70s. family history of thalassemia. uncle with diabetes. she denies family history of cancer, cad, or hypertension. physical exam: admission physical exam: vitals: t 91, bp 122/71, hr 82, rr 19, spo2 93% ra general: nad, comfortable heent: sclera anicteric, mmm, oropharynx clear, eomi, perrl neck: supple, no jvd appreciated, no ld cv: regular rate and rhythm, normal s1 + s2, no murmurs, rubs, gallops lungs: clear to auscultation bilaterally, no wheezes, rales, rhonchi abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound or guarding, epigastric hernia that is reducible, two large healed surgical scar from resection of cancer and cholecystectomy ext: warm, well perfused, 2+ pulses, 1+ edema up to knees neuro: cnii-xii intact, downgoing babinski discharge physical exam: vitals: t 98.4, bp 119/68, hr 80, rr 23, spo2 94% ra general: nad, comfortable heent: sclera anicteric, mmm, oropharynx clear, eomi, perrl neck: supple, no jvd appreciated, no ld cv: regular rate and rhythm, normal s1 + s2, no murmurs, rubs, gallops lungs: clear to auscultation bilaterally, no wheezes, rales, rhonchi abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound or guarding, epigastric hernia that is reducible, two large healed surgical scar from resection of cancer and cholecystectomy ext: warm, well perfused, 2+ pulses, 1+ edema up to knees neuro: cnii-xii intact pertinent results: admission labs: 10:05am blood wbc-3.7*# rbc-3.84* hgb-8.9* hct-27.8* mcv-72* mch-23.1* mchc-32.0 rdw-20.1* plt ct-211 10:05am blood neuts-48.9* lymphs-42.6* monos-7.1 eos-1.3 baso-0.2 10:05am blood pt-11.2 inr(pt)-1.0 10:05am blood urean-21* creat-0.8 na-143 k-3.6 cl-105 10:05am blood glucose-182* 10:05am blood totprot-6.9 albumin-4.3 globuln-2.6 calcium-8.9 phos-3.8 mg-1.6 10:05am blood alt-36 ast-32 alkphos-103 totbili-0.3 dirbili-0.1 indbili-0.2 01:48pm blood alt-35 ast-29 ld(ldh)-267* alkphos-112* totbili-0.3 10:05am blood ca125-40* discharge labs: 04:18am blood wbc-7.1# rbc-3.68* hgb-8.2* hct-26.1* mcv-71* mch-22.4* mchc-31.5 rdw-21.0* plt ct-202 04:18am blood glucose-156* urean-23* creat-0.9 na-141 k-4.3 cl-105 hco3-24 angap-16 04:18am blood alt-33 ast-29 alkphos-93 totbili-0.4 04:18am blood calcium-9.2 phos-4.1 mg-1.7 studies: none micro: none brief hospital course: 63f with stage iiic poorly differentiated primary peritoneal serous carcinoma, now with disease recurrence and participating in a clinical trial, admitted to the icu for cycle 5 of /taxol therapy with carboplatin desensitization. # carboplatin desensitization: cycle 2 was complicated by an allergic reaction after infusion of carboplatin which included a feeling of heat, generalized body tingling, numbness of the lips, chest tightness, nausea, and headache. patient was admitted to the icu for cycles 3 and 4 with carboplatin desensitization per protocol, and tolerated both cycles well. she underwent carboplatin desensitization per protocol for cycle 5 of /taxol and tolerated well. at discharge, she was feeling well, able to eat and denied any pain, fevers, tingling. # stage iiic poorly differentiated primary peritoneal serous carcinoma: status post sub-optimal debulking surgery () and 6 cycles of chemotherapy (/); five cycles with carboplatin and weekly taxol and 1 cycle with carboplatin and taxotere. ct torso on documented disease recurrence. on , she started chemotherapy according to the clinical trial #11-228 (phase ii, multi-center, double-blind, placebo controlled, randomized study of ombrabulin in patients with platinum-sensitive recurrent ovarian cancer treated with carboplatin/paclitaxel). the second cycle was complicated by an allergic reaction to carboplatin (see above), but cycles 3 and 4 were administered per the carboplatin desensitization protocol without complication. restaging ct torso performed on showed no new lesions, but there is mild interval enlargement of right retroperitoneal lymph nodes and left external iliac chain lymph node which could reflect progression of metastatic disease. she completed cycle 5 of chemotherapy during this admission per clinical trial #11-228 and tolerated desensitization well (above). qtc was monitored while receiving high doses of ondansetron and remained within normal limits. # prophylaxis: heparin sq # communication: patient # code: full code # transitional issue: -patient has follow up with heme/onc on medications on admission: preadmission medications listed are correct and complete. information was obtained from webomr. 1. ondansetron 8 mg po bid:prn nausea 2. lorazepam 0.5 mg po q8h:prn anxiety 3. docusate sodium 100 mg po bid 4. senna 1 tab po bid:prn constipation discharge disposition: home discharge diagnosis: carboplatin desensitization discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - independent. discharge instructions: dear ms. , it was a pleasure taking care of you during your hospitalization at . you were hospitalized to make sure that you did not have an adverse reaction while receiving your chemotherapy medications. you received your medications without any problems. please follow up with your cancer doctors. followup instructions: department: hematology/oncology when: tuesday at 8:45 am with: checkin hem onc cc9 building: sc clinical ctr campus: east best parking: garage department: hematology/oncology when: tuesday at 9:30 am with: , rn building: sc clinical ctr campus: east best parking: garage department: hematology/oncology when: monday at 7:45 am with: checkin hem onc cc9 building: sc clinical ctr campus: east best parking: garage procedure: injection or infusion of cancer chemotherapeutic substance diagnoses: esophageal reflux unspecified essential hypertension need for desensitization to allergens examination of participant in clinical trial secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes encounter for antineoplastic chemotherapy malignant neoplasm of specified parts of peritoneum thalassemia minor 

Answer: The patient is high likely exposed to